Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease: Background, Evolution, and Current Concerns
Open Access
- 1 January 2001
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 7 (1) , 6-16
- https://doi.org/10.3201/eid0701.010102
Abstract
Volume 22, Number 8—August 2016 - Emerging Infectious Disease journal - CDCKeywords
This publication has 43 references indexed in Scilit:
- Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humansProceedings of the National Academy of Sciences, 1999
- Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt‐Jakob disease in humansTransfusion, 1999
- Immunohistochemical evaluation of tonsillar tissue for preclinical screening of scrapie based on surveillance in BelgiumVeterinary Record, 1999
- Incubation period of Creutzfeldt–Jakob disease in human growth hormone recipients in FranceNeurology, 1999
- Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathyJournal of Chromatography A, 1999
- Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agentNature, 1997
- The risk of bovine spongiform encephalopathy ('mad cow disease') to human health.1997
- BSE: a decade on-part 2The Lancet, 1997
- BSE: a decade on—part IThe Lancet, 1997
- Decontamination of Creutzfeldt- Jakob Disease and other transmissible agentsJournal of NeuroVirology, 1997